Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate Mofetil + Corticosteroid in Advanced IgA Nephropathy
NCT02981212Phase 4Unknown
- Sponsor
- Yonsei University
- Start
- Jun 2016
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mycophenolate mofetil in IgA nephropathy (IgAN) (2 arms), sponsored by Yonsei University. Primary endpoint: Remission rate (complete / partial) at 48 weeks. Status: unknown.
02
Drugs
mycophenolate mofetil
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT02981212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02981212.